Yihong Jiang, Zeyu Zheng, Jing Zhu, Peng Zhang, Shaoheng Li, Yang Fu, Fei Wang, Zhuoru Zhang, Tong Chang, Min Zhang, Bai Ruan, Xiaocheng Wang
{"title":"The role of GDF15 in attenuating noise-induced hidden hearing loss by alleviating oxidative stress","authors":"Yihong Jiang, Zeyu Zheng, Jing Zhu, Peng Zhang, Shaoheng Li, Yang Fu, Fei Wang, Zhuoru Zhang, Tong Chang, Min Zhang, Bai Ruan, Xiaocheng Wang","doi":"10.1007/s10565-024-09912-2","DOIUrl":null,"url":null,"abstract":"<p>Noise-induced hidden hearing loss (HHL) is a newly uncovered form of hearing impairment that causes hidden damage to the cochlea. Patients with HHL do not have significant abnormalities in their hearing thresholds, but they experience impaired speech recognition in noisy environments. However, the mechanisms underlying HHL remain unclear. In this study, we developed single-cell transcriptome profiles of the cochlea of mice with HHL, detailing changes in individual cell types. Our study revealed a transient threshold shift, reduced auditory brainstem response wave I amplitude, and decreased number of ribbon synapses in HHL mice. Our findings suggest elevated oxidative stress and GDF15 expression in cochlear hair cells of HHL mice. Notably, the upregulation of GDF15 attenuated oxidative stress and auditory impairment in the cochlea of HHL mice. This suggests that a therapeutic strategy targeting GDF15 may be efficacious against HHL.</p><h3 data-test=\"abstract-sub-heading\">Graphical Abstract</h3><ol>\n<li>\n<span>1.</span>\n<p>HHL mice had a transient threshold shift, reduced ABR wave I amplitude, and decreased number of ribbon synapses.</p>\n</li>\n<li>\n<span>2.</span>\n<p>HHL mice's cochlear hair cells exhibited increased oxidative stress and elevated GDF15 expression.</p>\n</li>\n<li>\n<span>3.</span>\n<p>Upregulation of GDF15 attenuated oxidative stress and auditory damage in the cochlea of HHL mice, implying that GDF15-targeted treatment techniques may be useful for HHL.</p>\n</li>\n</ol>\n","PeriodicalId":9672,"journal":{"name":"Cell Biology and Toxicology","volume":"24 1","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Biology and Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10565-024-09912-2","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Noise-induced hidden hearing loss (HHL) is a newly uncovered form of hearing impairment that causes hidden damage to the cochlea. Patients with HHL do not have significant abnormalities in their hearing thresholds, but they experience impaired speech recognition in noisy environments. However, the mechanisms underlying HHL remain unclear. In this study, we developed single-cell transcriptome profiles of the cochlea of mice with HHL, detailing changes in individual cell types. Our study revealed a transient threshold shift, reduced auditory brainstem response wave I amplitude, and decreased number of ribbon synapses in HHL mice. Our findings suggest elevated oxidative stress and GDF15 expression in cochlear hair cells of HHL mice. Notably, the upregulation of GDF15 attenuated oxidative stress and auditory impairment in the cochlea of HHL mice. This suggests that a therapeutic strategy targeting GDF15 may be efficacious against HHL.
Graphical Abstract
1.
HHL mice had a transient threshold shift, reduced ABR wave I amplitude, and decreased number of ribbon synapses.
Upregulation of GDF15 attenuated oxidative stress and auditory damage in the cochlea of HHL mice, implying that GDF15-targeted treatment techniques may be useful for HHL.
期刊介绍:
Cell Biology and Toxicology (CBT) is an international journal focused on clinical and translational research with an emphasis on molecular and cell biology, genetic and epigenetic heterogeneity, drug discovery and development, and molecular pharmacology and toxicology. CBT has a disease-specific scope prioritizing publications on gene and protein-based regulation, intracellular signaling pathway dysfunction, cell type-specific function, and systems in biomedicine in drug discovery and development. CBT publishes original articles with outstanding, innovative and significant findings, important reviews on recent research advances and issues of high current interest, opinion articles of leading edge science, and rapid communication or reports, on molecular mechanisms and therapies in diseases.